News articles about Cognex (NASDAQ:CGNX) have been trending somewhat positive this week, Accern reports. The research group identifies negative and positive press coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Cognex earned a news sentiment score of 0.21 on Accern’s scale. Accern also assigned media stories about the scientific and technical instruments company an impact score of 45.6472378458778 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

Here are some of the news articles that may have impacted Accern Sentiment’s rankings:

Cognex (CGNX) traded down $0.09 on Tuesday, reaching $63.41. The company’s stock had a trading volume of 1,499,467 shares, compared to its average volume of 1,579,607. The firm has a market capitalization of $11,148.89, a price-to-earnings ratio of 47.51 and a beta of 1.50. Cognex has a 52 week low of $31.18 and a 52 week high of $72.99.

Cognex (NASDAQ:CGNX) last released its quarterly earnings results on Monday, October 30th. The scientific and technical instruments company reported $0.57 EPS for the quarter, topping the consensus estimate of $0.52 by $0.05. The company had revenue of $259.74 million for the quarter, compared to analyst estimates of $255.95 million. Cognex had a return on equity of 23.31% and a net margin of 34.77%. The firm’s revenue was up 75.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.31 earnings per share. research analysts expect that Cognex will post 1.39 EPS for the current year.

The business also recently announced a quarterly dividend, which was paid on Friday, December 1st. Stockholders of record on Friday, November 17th were issued a $0.045 dividend. This represents a $0.18 dividend on an annualized basis and a dividend yield of 0.28%. The ex-dividend date was Thursday, November 16th. Cognex’s payout ratio is currently 13.28%.

Several research analysts have commented on the company. ValuEngine lowered Cognex from a “hold” rating to a “sell” rating in a research report on Thursday, December 7th. BidaskClub lowered Cognex from a “buy” rating to a “hold” rating in a research report on Thursday, December 7th. J P Morgan Chase & Co lowered Cognex from a “neutral” rating to an “underweight” rating and set a $62.50 price target on the stock. in a research report on Wednesday, November 8th. Zacks Investment Research raised Cognex from a “hold” rating to a “buy” rating and set a $69.00 price target on the stock in a research report on Wednesday, November 1st. Finally, Canaccord Genuity lifted their price target on Cognex from $47.50 to $60.00 and gave the stock a “hold” rating in a research report on Tuesday, October 31st. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating and five have assigned a buy rating to the company’s stock. Cognex currently has a consensus rating of “Hold” and a consensus price target of $60.17.

In other news, Director Patrick Alias sold 5,000 shares of the business’s stock in a transaction that occurred on Monday, November 27th. The stock was sold at an average price of $143.54, for a total value of $717,700.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Theodor Krantz sold 15,000 shares of the business’s stock in a transaction that occurred on Thursday, November 9th. The shares were sold at an average price of $134.05, for a total value of $2,010,750.00. Following the completion of the transaction, the director now directly owns 26,250 shares in the company, valued at approximately $3,518,812.50. The disclosure for this sale can be found here. In the last three months, insiders sold 143,750 shares of company stock worth $18,540,975. Corporate insiders own 5.60% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Somewhat Positive Press Coverage Somewhat Unlikely to Impact Cognex (CGNX) Stock Price” was originally published by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another publication, it was stolen and republished in violation of US and international copyright and trademark laws. The correct version of this piece of content can be read at https://www.watchlistnews.com/somewhat-positive-press-coverage-somewhat-unlikely-to-impact-cognex-cgnx-stock-price/1760040.html.

About Cognex

Cognex Corporation (Cognex) is a provider of machine vision products that capture and analyze visual information in order to automate tasks, primarily in manufacturing processes, where vision is required. The Company operates through the machine vision technology segment. The Company’s machine vision products are used to automate the manufacture and tracking of discrete items, such as mobile phones, aspirin bottles and automobile tires, by locating, identifying, inspecting and measuring them during the manufacturing or distribution process.

Insider Buying and Selling by Quarter for Cognex (NASDAQ:CGNX)

Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with Analyst Ratings Network's FREE daily email newsletter.